Cargando…
MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison
BACKGROUND: After neoadjuvant therapy, most of the lymph nodes (LNs) will shrink and disappear in patients with rectal cancer. However, LNs that are still detectable on MRI carry a risk of metastasis. This study aimed to evaluate the performance of the European Society of Gastrointestinal and Abdomi...
Autores principales: | Zhang, Zhiwen, Chen, Yan, Wen, Ziqiang, Wu, Xuehan, Que, Yutao, Ma, Yuru, Wu, Yunzhu, Liu, Quanmeng, Fan, Wenjie, Yu, Shenping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339540/ https://www.ncbi.nlm.nih.gov/pubmed/37443085 http://dx.doi.org/10.1186/s40644-023-00589-0 |
Ejemplares similares
-
Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023) -
Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal Adenocarcinoma
por: Aryan, Mahmoud, et al.
Publicado: (2021) -
Preoperative T and N Restaging of Rectal Cancer After Neoadjuvant Chemoradiotherapy: An Accuracy Comparison Between MSCT and MRI
por: Liu, Wenjuan, et al.
Publicado: (2022) -
Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging?
por: Heijnen, Luc A., et al.
Publicado: (2016) -
The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Liu, Guo-Chen, et al.
Publicado: (2015)